Biochemical abnormalities in the retinal pigment epithelium of experimentally diabetic animals include increased sorbitol and decreased myo-inositol. Diabetes also causes a progressive reduction in the amplitude of the c-wave of the electroretinogram of the pigmented rat. The c-wave is generated by the retinal pigmented epithelium. Myo-inositol administration or treatment with sorbinil, an inhibitor of aldose reductase, arrested the decline in the c-wave. Therefore, hyperglycemia-associated defects in myo-inositol or sorbitol metabolism may be involved in the pathogenesis of the electrophysiological deficit of the diabetic retina. The homogeneous cell layer of the pigment epithelium may be a useful tissue model for studying the pathogenesis of the complications of diabetes.
Introduction
Vascular lesions of the retina are the major cause of blindness associated with diabetes of long duration (1) . However, morphological, biochemical, and functional changes develop in the retina within several weeks of experimental induction of diabetes, long before vascular alterations are apparent. Pathological changes have been documented in the retinal pigmented epithelium (RPE)', the cell layer that constitutes the outer blood retinal barrier. In experimental diabetes of a few weeks duration, the basal membrane of the RPE cells doubles in surface area and infolding (2) , and increased dye permeability is observed (3, 4) . The glucose concentration in the RPE is equal to serum level in normal and in diabetic animals (5) . The RPE and all retinal layers in early diabetes show increased sorbitol and decreased myo-inositol (5) . Electrophysiological impairment is evident in the progressive decrease in the amplitude of the c-wave of the electroretinogram (ERG) of the acutely diabetic rat (6) . The normal c-wave of the ERG is associated with hyperpolarization of the apical membranes of the RPE cells, which occurs passively in response to decreased potassium in the outer retinal extracellular space after lightinduced hyperpolarization of photoreceptor cells (7) .
Electrophysiological deficits are documented in nerve as well as in retina of early diabetic animals, and may share a common pathogenesis. Elevated serum glucose also causes reduced myo-inositol and increased sorbitol in peripheral nerves of diabetic animals (8) (9) (10) (11) (12) (13) . These defects are associated with reduced nerve conduction velocity (10) (11) (12) Correction of the hyperglycemia-associated sorbitol accumulation or myo-inositol decrease in nerve prevents the development of neural electrophysiological deficits in diabetic rats (10) (11) (12) . Therefore, the present study was initiated to determine whether myo-inositol supplementation or sorbinil treatment alters the progressive decrease in the c-wave amplitude of the ERG of acutely diabetic rats.
Methods
Male pigmented Long-Evans rats that weighed 230-280 g at the beginning of the study were fed rat chow (Ralston Purina Co., St. Louis, MO) ad lib. The myo-inositol content of the rat chow, kindly analyzed by Dr. D. A. Greene with a previously described method (10), was 20 mg per 100 g chow. ERG recordings were taken on all rats, which were then randomly assigned to normal or diabetic groups in each treatment category. After a 16-h fast on the evening of the first ERG, diabetes was induced by intraperitoneal injection of streptozotocin (70 mg/kg in 1.5 ml 0.9% saline, pH 4.5; Sigma Chemical Co., St. Louis, MO). Diabetes was confirmed by fasting serum glucose levels over 15 mM both 3 d and 6 wk after induction. Serum glucose was measured with a glucose analyzer (II; Beckman Instruments, Inc., Fullerton, CA) and serum myo-inositol was measured enzymatically (14) . Treatments were begun the evening of streptozotocin injection, and consisted of a total daily dose of either 650 mg/kg myo-inositol or 10 mg/kg sorbinil divided into two equal doses and administered by gavage every 12 h. At these doses, myo-inositol prevents peripheral nerve abnormalities (I1) and sorbinil is present and active within the eye (15) . Sorbinil, kindly supplied by Pfizer Chemicals Div. (Groton, CT), was solubilized as previously described (13) . Direct ophthalmological examination of the eyes of each rat after the last ERG revealed no abnormalities.
For ERG recordings, the rats were weighed, then dark-adapted for 24 h. Each rat was anesthetised with ketamine (87 mg/kg; Parke, Davis & Co., Detroit, MI) and xylazine (20 mg/kg; Bay Vet, Div. Cutter Laboratories, Inc., Shawnee, KS), both intramuscular. The ERG responses were recorded with a bipolar contact lens electrode (BurienAllen; from Hansen Ophthalmic Development Laboratory, Iowa City, IA) and an ear clamp reference electrode. The lens electrode was inserted, and the pupil was dilated with 1% tropicamide (Alcon Labs., Inc., Fort Worth, TX). The rat was positioned so that its head and shoulders extended into a full-field (ganzfeld) diffusing sphere, with recessed light source that produced illumination of 3.0 footlamberts within the sphere. After 30 min, a 10-s light stimulus was applied. Direct current potentials were recorded on a flat bed plotter and storage oscilloscope after preamplification of 1,000-fold. A variable potential of ±500 mV was introduced between the lens electrode and the preamplifier to eliminate direct current potential offset caused by the interaction of various metal components of the electrode. ERG bwave and c-wave amplitudes were measured in microvolts at the points of maximum deflection from the isoelectric line during the first 6 s of the 10-s stimulus.
The statistical significance of measured differences between experimental groups was calculated using Student's t test.
Results
Fasting serum glucose, measured in blood collected by heart puncture after the final ERG, averaged 8.4±0.2 mM (mean±SE, n = 23) in normal rats and 24.8±0.7 mM (n = 31) in diabetics. Final body weights averaged 413±5 g (n = 23) for normals, and 254±6 g (n = 31) for diabetics. Treatment with sorbinil or with myo-inositol had no effect (P . 0.05) on serum glucose levels or body weights, shown by similar means and ranges in treated and untreated groups. Serum myo-inositol averaged 211±12 ,M (n = 15) in myo-inositol supplemented animals and 45±2 uM (n = 38) in untreated and sorbinil treated rats. These averaged values include normal and diabetic rat sera, since diabetes caused no significant change in measured serum myo-inositol.
Representative ERG recordings are shown in Fig. 1 . There was no significant difference in the b-wave amplitudes of the different groups. After 2 wk of diabetes, the c-wave was significantly reduced (P < 0.001) in all diabetics (Fig. 2) . The c-wave amplitude continued to decrease in untreated diabetics, but was maintained by either myo-inositol or sorbinil treatment at the 2-wk level. With either treatment, peak c-waves of the diabetics were still significantly less than respective control groups, with the exception of the myo-inositol treatment group at 4 wk. The c-wave amplitude of diabetics treated with myo-inositol was significantly higher than the untreated diabetic response at both the 4-wk (P . 0.01) and 6-wk (P < 0.00001) time points. The response of sorbinil-treated diabetics was significantly different than untreated diabetics (P . 0.00005) after 6 wk of treatment, but not after 4 wk. Mean c-wave amplitudes of normal untreated rats were significantly lower than in the initial ERG after 4 wk (P < 0.01) and 6 wk (P < 0.05). Although there was no significant change in c-wave response of myo-inositol-treated normal rats over the study period, the c-wave amplitudes of sorbinil-treated normals were less (P < 0.002) than pretreatment recordings after 4 wk, but not after 6 wk.
The small (statistically nonsignificant) trend in our recordings over time was associated with polarization of the complex corneal electrode. To offset this factor, all ERG recordings for each of the four time points were collected within several days, with those of diabetic and nondiabetic animals recorded alternately. Therefore, the differences in c-wave peak between diabetic and nondiabetic rats appear to be valid.
Discussion
A trend toward decrease of peak c-wave amplitudes of the treated and untreated nondiabetic rats appeared to be present over the 6 wk of this study. Using similar animals and methods, but recording with a saline wick electrode, Pautler and Ennis (6) observed no change in peak c-wave values in nondiabetic rats over 19 wk.
The reduction of the c-wave of diabetic pigmented rats in this study, similar to previously reported measurements (6) , MYO may reflect impaired ability of the apical cell membranes to hyperpolarize in response to reduced extracellular potassium. Decreased polarization responses might be associated with altered ion metabolism of the RPE, similar to that described in nerves of diabetics (16, 17) . We have shown that either myo-inositol supplementation or sorbinil treatment also arrests the progressive reduction in the c-wave of the ERG of the diabetic pigmented rat. This is significant because an association is made between abnormal myo-inositol and sorbitol metabolism in diabetes and impaired electrophysiological response of a single cell layer. Note that in this context, alloxan diabetes causes a loss of Na'-K+-ATPase activity and an elevation of the sodium content of the RPE of the rabbit (18, 19) . This result is similar to the known diabetic manifestations in peripheral nerve of diabetic animals (16, 17, 20) . Extrapolating from the results of sorbinil treatment or dietary myo-inositol supplementation on measured nerve Na'-K+-ATPase activity (20, 21) , it can be postulated that treatments would also prevent the Na'-K+-ATPase loss and sodium accumulation in the RPE. This prediction is testable. It must be emphasized, however, that a biochemically plausible linkage between hyperglycemia, enhanced polyol pathway, myo-inositol depletion, lowering of Na'-K+-ATPase activity, sodium accumulation, and electrophysiological abnormalities cannot be made at this juncture.
The RPE, as the major component of the outer blood retinal barrier, is pivotal in determining the composition of the retinal extracellular fluid. Diabetes-related changes in this layer which altered the extracellular environment of the retinal capillaries might be involved in the pathogenesis of microvascular diabetic retinopathy. The cells of the retinal pigment epithelium may provide a unique model for studying the molecular basis of diabetic complications and their prevention or reversal.
